The impact of cancer related fibroblasts-derived exosomes on promoting the invasion and metastasis of osteosarcoma
Chen Chenglong1, 2, Sun Xuejiao3, Li Zhihu4, Sun Xiaojuan2, Han Pengfei1,2, Zhang Long2, Lyu Zhi5
1Department of Orthopaedics, the Second Clinical Medical College of Shanxi Medical University, Taiyuan 030001, China; 2Department of Orthopaedics, the Second Hospital of Shanxi Medical University, Shanxi Key Laboratory of Bone and Soft Tissue Injury Repair, Taiyuan 030001, China; 3Department of Biochemistry and Molecular Biology, School of Basic Medicine, Shanxi Medical University, Taiyuan 030001, China; 4Department of Clinical Medicine, the Second Clinical Medical College of Shanxi Medical University, Taiyuan 030001, China; 5Department of Orthopaedics, the Second Hospital of Shanxi Medical University, Taiyuan 030001, China
Abstract：Objective To investigate the impact of cancer related fibroblasts-derived exosomes on promoting invasion and metastasis of osteosarcoma.Methods The osteosarcoma cell line Saos-2 was used to isolate cancer-associated fibroblasts (CAFs). Exosomes extract from the supernatants of CAFs and the morphology of exosomes was identified by electron microscopy. The expression of exosome-specific marker protein β-actin, CD63 were detected by Western blot. Cell scratches and Transwell chamber experiments were used to observe the effects of exosomes on the migration and invasion of Saos-2 cells. Twelve female BALB/c-nu nude mice of 5 weeks old were randomly divided into exosomes and control groups, with 6 in each group. The two groups were subcutaneously implanted by subcutaneous inoculation of human osteosarcoma Saos-2 cells and Matrigel mixed suspension to establish a nude mouse osteosarcoma model. Tail vein injection was performed after modeling. The exosome group was injected with a concentration of 0.1 μg/μL of exosome suspension through the tail vein, 30 μL per nude mouse, once a week, for a total of 6 injections. Mice in the control group were injected with normal saline at the same dose. After the first injection, the tumor formation of the nude mice was observed daily. After one week of tumor implantation, the nude mice had a subcutaneous lesion on the right side. The longest diameter and the largest vertical orthogonal diameter of the two groups were measured, and the tumor volume was calculated, and then measured once a week for a total of 6 weeks. After the last measurement was completed, euthanasia was performed, and the lump was completely removed and weighed. The lung tissue of nude mice was taken for HE staining to observe the lung metastasis of the two groups.Results Under microscope, the CAFs showed long fusiform shape and disordered arrangement. Immunohistochemical staining showed that the expression of α-SMA protein in CAFs was positive, suggesting that CAFs were successfully extracted. Exosomes were observed by Electron microscopy as the round and elliptical membranous vesicular structure of 70-100 nm. The results of Western blot showed that CD63 protein was highly expressed in exosomes, and β-actin protein expression was weak, suggesting successful isolation of CAFs derived from exosomes. The scratch test and invasion test showed that the migration distance, migration rate and number of invasive cells in exosomes group were (0.19±0.02) mm, 0.81%±0.11%, and (53.67±5.69),respectively,which were higher than those in control group (0.81±0.11) mm, 0.32%±0.11%, and (31.67±8.08), with statistically significant differences (t=6.209, 6.209, and 3.856, all P values＜0.01). The nude mice in both groups reached the tumor one week after the first injection of tumor cells, and the tumor volume increased with time (F=49.428, 8.477, all P values＜0.05). There was no significant difference between the two groups in the first and second measurement of tumor volume (P＞0.05). The third to sixth measurement of tumor volume were higher in the exosomes than in the control group (t=4.697, 4.825, 3.516, 2.706, all P values＜0.05). After six measurements, the nude mice were sacrificed and the tumors were removed. The tumor mass of the exosomes group (1.62±0.29) g was greater than that of the control group (1.00±0.43) g, and the difference was statistically significant (t=2.929, P＜0.05). HE staining of lung tissue sections showed that lung metastasis occurred in both nude mice. The number of lung tissue metastases in the Exo group was 6.63(3, 17), which was significantly higher than that in the control group 1.17(0, 3). The difference was statistically significant (W=36.000, P＜0.01).Conclusions CAFs-derived exosomes can promote the migration and invasion of osteosarcoma cell line Saos-2, and facilitate the osteosarcoma growth and lung metastasis.
陈成龙, 孙雪娇, 李志慧, 孙晓娟, 韩鹏飞, 张龙, 吕智. 癌相关成纤维细胞来源的外泌体在促骨肉瘤侵袭转移中作用的实验研究[J]. 中华解剖与临床杂志, 2019, 24(4): 332-340.
Chen Chenglong, Sun Xuejiao, Li Zhihu, Sun Xiaojuan, Han Pengfei, Zhang Long, Lyu Zhi. The impact of cancer related fibroblasts-derived exosomes on promoting the invasion and metastasis of osteosarcoma. Chinese Journal of Anatomy and Clinics, 2019, 24(4): 332-340.
Sakamoto A, Iwamoto Y. Current status and perspectives regarding the treatment of osteo-sarcoma: Chemotherapy[J]. Rev Recent Clin Trials, 2008, 3(3): 228-231. DOI:10.2174/157488708785700267.
[2]
Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma[J]. Curr Opin Pharmacol, 2014, 16: 15-23. DOI:10.1016/j.coph.2014.02.002.
[3]
Ferguson WS, Goorin AM. Current treatment of osteosarcoma[J]. Cancer Invest, 2001, 19(3): 292-315. DOI:10.1081/cnv-100102557.
[4]
Li S, Sun W, Wang H, et al. Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal[J]. Tumour Biol, 2015, 36(3): 1329-1338. DOI:10.1007/s13277-015-3181-0.
[5]
Yu DD, Wu Y, Shen HY, et al. Exosomes in development, metastasis and drug resistance of breast cancer[J]. Cancer Sci, 2015, 106(8): 959-964. DOI:10.1111/cas.12715.
[6]
Fontana S, Saieva L, Taverna S, et al. Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives[J]. Proteomics, 2013, 13(10-11): 1581-1594. DOI:10.1002/pmic.201200398.
[7]
Vallabhaneni KC, Penfornis P, Dhule S, et al. Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites[J]. Oncotarget, 2015, 6(7): 4953-4967. DOI:10.18632/oncotarget.3211.
Tang X, Hou Y, Yang G, et al. Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling[J]. Cell Death Differ, 2016, 23(1): 132-145. DOI:10.1038/cdd.2015.78.
He GH, Zhang W, Ma YX, et al. Mesenchymal stem cells-derived exosomes ameliorate blue light stimulation in retinal pigment epithelium cells and retinal laser injury by VEGF-dependent mechanism[J]. Int J Ophthalmol, 2018, 11(4): 559-566. DOI:10.18240/ijo.2018.04.04.
[12]
Ramteke A, Ting H, Agarwal C, et al. Exosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction molecules[J]. Mol Carcinog, 2015, 54(7): 554-565. DOI:10.1002/mc.22124.
[13]
Ying W, Riopel M, Bandyopadhyay G, et al. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity[J]. Cell, 2017, 171(2): 372-384.e12. DOI:10.1016/j.cell.2017.08.035.
[14]
Zhang Y, Kim MS, Jia B, et al. Hypothalamic stem cells control ageing speed partly through exosomal miRNAs[J]. Nature, 2017, 548(7665): 52-57. DOI:10.1038/nature23282.
[15]
Sun X, Charbonneau C, Wei L, et al. Mir-181a targets RGS16 to promote chondrosarcoma growth, angiogenesis, and metastasis[J]. Mol Cancer Res, 2015, 13(9): 1347-1357. DOI:10.1158/1541-7786.MCR-14-0697.
Bielack SS, Hecker-Nolting S, Blattmann C, et al. Advances in the management of osteosarcoma[J]. F1000Res, 2016, 5: 2767. DOI:10.12688/f1000research.9465.1.
[19]
Miller BJ, Cram P, Lynch CF, et al. Risk factors for metastatic disease at presentation with osteosarcoma: An analysis of the SEER database[J]. J Bone Joint Surg Am, 2013, 95(13): e89. DOI:10.2106/JBJS.L.01189.
[20]
Li P, Shan JX, Chen XH, et al. Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment[J]. Cell Res, 2015, 25(5): 588-603. DOI:10.1038/cr.2015.51.
[21]
Zhao H, Yang L, Baddour J, et al. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism[J]. Elife, 2016, 5: e10250. DOI:10.7554/eLife.10250.
[22]
Huang WT, Chong IW, Chen HL, et al. Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1[J]. Cancer Lett, 2019, 442: 287-298. DOI:10.1016/j.canlet.2018.10.031.
[23]
Singh R, Pochampally R, Watabe K, et al. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer[J]. Mol Cancer, 2014, 13: 256. DOI:10.1186/1476-4598-13-256.
Klymiuk MC, Balz N, Elashry MI, et al. Exosomes isolation and identification from equine mesenchymal stem cells[J]. BMC Vet Res, 2019, 15(1): 42. DOI:10.1186/s12917-019-1789-9.
[26]
Khushman M, Bhardwaj A, Patel GK, et al. Exosomal markers (CD63 and CD9) expression pattern using immunohistochemistry in resected malignant and nonmalignant pancreatic specimens[J]. Pancreas, 2017, 46(6): 782-788. DOI:10.1097/MPA.0000000000000847.
[27]
Verweij FJ, Revenu C, Arras G, et al. Live tracking of inter-organ communication by endogenous exosomes in vivo[J]. Dev Cell, 2019, 48(4): 573-589.e4. DOI:10.1016/j.devcel.2019.01.004.
Zhou W, Fong MY, Min Y, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis[J]. Cancer Cell, 2014, 25(4): 501-515. DOI:10.1016/j.ccr.2014.03.007.
[30]
Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver[J]. Nat Cell Biol, 2015, 17(6): 816-826. DOI:10.1038/ncb3169.
[31]
Zhang H, Deng T, Liu R, et al. Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis[J]. Nat Commun, 2017, 8: 15016. DOI:10.1038/ncomms15016.
Baker EK, Taylor S, Gupte A, et al. Wnt inhibitory factor 1 (WIF1) is a marker of osteoblastic differentiation stage and is not silenced by DNA methylation in osteosarcoma[J]. Bone, 2015, 73: 223-232. DOI:10.1016/j.bone.2014.12.063.
[34]
de Vrij J, Maas SL, Kwappenberg KM, et al. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells[J]. Int J Cancer, 2015, 137(7): 1630-1642. DOI:10.1002/ijc.29521.
[35]
Gong L, Bao Q, Hu C, et al. Exosomal miR-675 from metastatic osteosarcoma promotes cell migration and invasion by targeting CALN1[J]. Biochem Biophys Res Commun, 2018, 500(2): 170-176. DOI:10.1016/j.bbrc.2018.04.016.
[36]
Wang Z, Chen JQ, Liu JL, et al. Exosomes in tumor microenvironment: novel transporters and biomarkers[J]. J Transl Med, 2016, 14(1): 297. DOI:10.1186/s12967-016-1056-9.
[37]
Chen W, Jiang J, Xia W, et al. Tumor-related exosomes contribute to tumor-promoting microenvironment: an immunological perspective[J]. J Immunol Res, 2017, 2017: 1073947. DOI:10.1155/2017/1073947.
2019, Vol. 24 
